Community/Retail

Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.

There are several new treatments in the pipeline that hold promise for patients with type 2 diabetes.

Sessions focuses on new diabetes treatment options.

Two new fixed-dose basal/GLP-1 receptor-agonist agents, Soliqua 100/33 (Sanofi) and Xultophy 100/3.6 (Novo Nordisk), were approved by the FDA in November 2016.

In this clip, Jeffrey Fudin, PharmD, who spoke at APHA 2017 on opioid tapering, discusses options pharmacists should consider when tapering patients.

Failing to secure sufficient support for their proposed Affordable Care Act (ACA) replacement, Republicans leaders have pulled the American Health Care Act (AHCA) from the House floor, cancelling a scheduled vote on the health care legislation

In this clip, Jeffrey Fudin, PharmD, discusses available options in abuse-deterrent formulations of opioids.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The FDA granted accelerated approval to the first treatment for metastatic Merkel cell carcinoma (MCC).

New research indicates that high consumption of certain dairy products may either increase or decrease the risk of developing breast cancer, depending on the food.

Everybody seems to use social media, and pharmacists are no exception. However, it's been unclear how pharmacists employ social media in their daily professional practice.

The SpartanNash Foundation recently presented a $5,000 grant to Ruth Meiers Hospitality House of Bismarck, helping them to provide access to daily meals, laundry facilities, showers, computers, and case management services to the homeless and those at risk of homelessness in the community.

CVS Health, the University of Pittsburgh School of Pharmacy, and the Pittsburgh Public Schools have announced a unique public-private partnership that will bring CVS Health's prescription drug abuse prevention program to students in the Pittsburgh Public Schools.

The National Community Pharmacists Association (NCPA) is proud to announce a new strategic partnership with the PRS Pharmacy Services (PRS).

APhA is about to kick off and we'll be there all weekend covering it live!

The meningitis outbreak trial involving the New England Compounding Center (NECC) pharmacist Barry Cadden has reached a final verdict.

The composition of our classes has changed in many ways.

The US Veterans Administration (VA) health care system is the largest in the United States, serving 22 million former military members.

Eli Lilly and Company recently announced positive late-stage results in its clinical trial testing a combination of its experimental breast cancer drug and another widely-used treatment.

The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.

Have you ever considered pursuing a PGY-2 pharmacy residency in critcal care?

The FDA has approved Newron Pharmaceutical’s Xadago (safinamide), an add-on treatment for patients with Parkinson’s disease.

An estimated 86 million Americans have prediabetes, and 90% of them don't know they have it.

Several public health and antismoking groups are urging the FDA to enforce more stringent regulations on the manufacturing of tobacco products by banning candy and fruit-flavored e-cigarettes and cigars.

Metformin saves lives

Working in sales was so appealing to Brad that he decided to start his own business as a manufacturing representative.

An interdisciplinary treatment modality is especially effective when treating patients with chronic pain.

Personalizing doses of warfarin through genetic testing helped reduce the risk of combined adverse events in patients undergoing elective orthopedic surgery, according to data presented at the American College of Cardiology's 66th Annual Scientific Session.

The American Society of Clinical Oncology (ASCO) released a clinical practice guideline on human papillomavirus (HPV) vaccination for the primary prevention of cervical cancer.